However, some studies reported an exceptionally high CD133 (20–60%) fraction in some human glioblastoma and/or glioma cell lines (7), and other authors also have reported that glioblastoma contain more than 25% of CD133-positive cells (8). This evidence concerns the gene PROM1 and glioblastoma.